IS5251A - 9-oxím erýþrómýsín afleiður - Google Patents

9-oxím erýþrómýsín afleiður

Info

Publication number
IS5251A
IS5251A IS5251A IS5251A IS5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A
Authority
IS
Iceland
Prior art keywords
erythromycin derivatives
oxime erythromycin
oxime
derivatives
erythromycin
Prior art date
Application number
IS5251A
Other languages
English (en)
Inventor
Wu Yong-Jin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5251A publication Critical patent/IS5251A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IS5251A 1997-06-11 1999-11-16 9-oxím erýþrómýsín afleiður IS5251A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
IS5251A true IS5251A (is) 1999-11-16

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5251A IS5251A (is) 1997-06-11 1999-11-16 9-oxím erýþrómýsín afleiður

Country Status (31)

Country Link
EP (1) EP0988308A1 (is)
JP (1) JP2000513026A (is)
KR (1) KR20010013660A (is)
CN (1) CN1259135A (is)
AP (1) AP9801253A0 (is)
AR (1) AR012244A1 (is)
AU (1) AU7226798A (is)
BG (1) BG103947A (is)
BR (1) BR9810021A (is)
CA (1) CA2293335A1 (is)
CO (1) CO4940506A1 (is)
CZ (1) CZ9904388A3 (is)
EA (1) EA199901016A1 (is)
GT (1) GT199800074A (is)
HN (1) HN1998000073A (is)
HR (1) HRP980316A2 (is)
HU (1) HUP0002252A3 (is)
ID (1) ID24529A (is)
IL (1) IL132767A0 (is)
IS (1) IS5251A (is)
MA (1) MA26505A1 (is)
NO (1) NO996108L (is)
OA (1) OA11225A (is)
PA (1) PA8451801A1 (is)
PE (1) PE79899A1 (is)
PL (1) PL337606A1 (is)
TN (1) TNSN98083A1 (is)
TR (1) TR199902995T2 (is)
TW (1) TW448174B (is)
WO (1) WO1998056800A1 (is)
ZA (1) ZA985018B (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
WO2000017218A1 (en) * 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
AU775637B2 (en) * 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
ATE250076T1 (de) * 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
HUP0002252A2 (hu) 2000-12-28
AP9801253A0 (en) 1999-12-04
CO4940506A1 (es) 2000-07-24
BR9810021A (pt) 2000-09-19
JP2000513026A (ja) 2000-10-03
GT199800074A (es) 1999-11-27
HUP0002252A3 (en) 2002-01-28
HRP980316A2 (en) 1999-04-30
HN1998000073A (es) 1999-01-08
CZ9904388A3 (cs) 2002-10-16
KR20010013660A (ko) 2001-02-26
NO996108L (no) 2000-02-10
EA199901016A1 (ru) 2000-06-26
OA11225A (en) 2003-07-17
WO1998056800A1 (en) 1998-12-17
IL132767A0 (en) 2001-03-19
CN1259135A (zh) 2000-07-05
MA26505A1 (fr) 2004-12-20
TW448174B (en) 2001-08-01
AU7226798A (en) 1998-12-30
AR012244A1 (es) 2000-09-27
CA2293335A1 (en) 1998-12-17
ZA985018B (en) 1999-12-10
TR199902995T2 (xx) 2000-02-21
PE79899A1 (es) 1999-08-25
NO996108D0 (no) 1999-12-10
TNSN98083A1 (fr) 2005-03-15
ID24529A (id) 2000-07-20
PA8451801A1 (es) 2000-05-24
BG103947A (en) 2000-07-31
PL337606A1 (en) 2000-08-28
EP0988308A1 (en) 2000-03-29

Similar Documents

Publication Publication Date Title
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
ATE377018T1 (de) Erythromycinderivate
IS5528A (is) Ný makrólíð
IL132767A0 (en) 9-Oxime erythromycin derivatives
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
DK0941998T3 (da) 3,6-ketalmakrolidantibiotika
NO20015172D0 (no) 1-Metyl-erytromycin-derivater
EE200100394A (et) Ketoliidsed antibiootikumid
EE200100245A (et) Uued makroliidsed antibiootikumid
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
NO980016D0 (no) Makrolider
EP1167375A4 (en) ERYTHROMYCIN DERIVATIVES
LV11898A (lv) Eritromicina atvasinajumi
EP0766685A4 (en) ARYL, ALKYL, ALKENYL AND ALKINYL MACROLID
ZA983902B (en) Erythromycin derivatives.
EP1044985A4 (en) ERYTHROMYCIN
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
GB9700702D0 (en) Erythromycin derivatives
ZA989845B (en) 2-halo-6-O-substituted ketolide derivatives
SI1027362T1 (sl) 2-halo-6-O-substituirani derivati ketolidov